Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 146

1.

Bupropion sustained release for panic disorder.

Simon NM, Emmanuel N, Ballenger J, Worthington JJ, Kinrys G, Korbly NB, Farach FJ, Pollack MH.

Psychopharmacol Bull. 2003;37(4):66-72.

PMID:
15131517
2.

An open trial of bupropion for the treatment of adults with attention-deficit/hyperactivity disorder and bipolar disorder.

Wilens TE, Prince JB, Spencer T, Van Patten SL, Doyle R, Girard K, Hammerness P, Goldman S, Brown S, Biederman J.

Biol Psychiatry. 2003 Jul 1;54(1):9-16.

PMID:
12842303
3.

A randomized controlled trial of venlafaxine ER and paroxetine in the treatment of outpatients with panic disorder.

Pollack M, Mangano R, Entsuah R, Tzanis E, Simon NM, Zhang Y.

Psychopharmacology (Berl). 2007 Oct;194(2):233-42. Erratum in: Psychopharmacology (Berl). 2008 Feb;196(2):339. Zhang, Ying [added].

PMID:
17589833
4.

Predictors and time course of response among panic disorder patients treated with cognitive-behavioral therapy.

Aaronson CJ, Shear MK, Goetz RR, Allen LB, Barlow DH, White KS, Ray S, Money R, Saksa JR, Woods SW, Gorman JM.

J Clin Psychiatry. 2008 Mar;69(3):418-24.

PMID:
18278989
5.

Relapse prevention of panic disorder in adult outpatient responders to treatment with venlafaxine extended release.

Ferguson JM, Khan A, Mangano R, Entsuah R, Tzanis E.

J Clin Psychiatry. 2007 Jan;68(1):58-68.

PMID:
17284131
6.

A double-blind study of the efficacy of venlafaxine extended-release, paroxetine, and placebo in the treatment of panic disorder.

Pollack MH, Lepola U, Koponen H, Simon NM, Worthington JJ, Emilien G, Tzanis E, Salinas E, Whitaker T, Gao B.

Depress Anxiety. 2007;24(1):1-14.

PMID:
16894619
7.

A placebo-controlled trial of bupropion SR in the treatment of chronic posttraumatic stress disorder.

Becker ME, Hertzberg MA, Moore SD, Dennis MF, Bukenya DS, Beckham JC.

J Clin Psychopharmacol. 2007 Apr;27(2):193-7.

PMID:
17414245
8.

Medication augmentation after the failure of SSRIs for depression.

Trivedi MH, Fava M, Wisniewski SR, Thase ME, Quitkin F, Warden D, Ritz L, Nierenberg AA, Lebowitz BD, Biggs MM, Luther JF, Shores-Wilson K, Rush AJ; STAR*D Study Team..

N Engl J Med. 2006 Mar 23;354(12):1243-52.

9.

The efficacy of milnacipran in panic disorder: an open trial.

Blaya C, Seganfredo AC, Dornelles M, Torres M, Paludo A, Heldt E, Manfro GG.

Int Clin Psychopharmacol. 2007 May;22(3):153-8.

PMID:
17414741
10.

Bupropion SR vs placebo for smoking cessation in health care professionals.

Zellweger JP, Boelcskei PL, Carrozzi L, Sepper R, Sweet R, Hider AZ.

Am J Health Behav. 2005 May-Jun;29(3):240-9.

PMID:
15899687
12.

A prospective trial of sustained-release bupropion for depression in HIV-seropositive and AIDS patients.

Currier MB, Molina G, Kato M.

Psychosomatics. 2003 Mar-Apr;44(2):120-5.

PMID:
12618534
13.

[Efficacy and tolerability of escitalopram in anxiety disorders: a review].

Pelissolo A.

Encephale. 2008 Sep;34(4):400-8. doi: 10.1016/j.encep.2008.04.004. Review. French.

PMID:
18922243
14.

Open-label support for duloxetine for the treatment of panic disorder.

Simon NM, Kaufman RE, Hoge EA, Worthington JJ, Herlands NN, Owens ME, Pollack MH.

CNS Neurosci Ther. 2009 Winter;15(1):19-23. doi: 10.1111/j.1755-5949.2008.00076.x.

PMID:
19228176
15.

Sustained-release bupropion versus naltrexone in the treatment of pathological gambling: a preliminary blind-rater study.

Dannon PN, Lowengrub K, Musin E, Gonopolski Y, Kotler M.

J Clin Psychopharmacol. 2005 Dec;25(6):593-6.

PMID:
16282845
16.

Efficacy of sustained-release bupropion in neuropathic pain: an open-label study.

Semenchuk MR, Davis B.

Clin J Pain. 2000 Mar;16(1):6-11.

PMID:
10741812
17.

Bupropion for patients with obsessive-compulsive disorder: an open-label, fixed-dose study.

Vulink NC, Denys D, Westenberg HG.

J Clin Psychiatry. 2005 Feb;66(2):228-30.

PMID:
15705009
18.

Bupropion sustained-release for the treatment of dysthymic disorder: an open-label study.

Hellerstein DJ, Batchelder S, Kreditor D, Fedak M.

J Clin Psychopharmacol. 2001 Jun;21(3):325-9.

PMID:
11386496
19.

Double-blind, randomized trial of bupropion SR for the treatment of neuropathic pain.

Semenchuk MR, Sherman S, Davis B.

Neurology. 2001 Nov 13;57(9):1583-8.

PMID:
11706096
20.

An open-label trial of risperidone augmentation for refractory anxiety disorders.

Simon NM, Hoge EA, Fischmann D, Worthington JJ, Christian KM, Kinrys G, Pollack MH.

J Clin Psychiatry. 2006 Mar;67(3):381-5.

PMID:
16649823
Items per page

Supplemental Content

Support Center